PYRAMID registry: An observational study of adalimumab in Crohn's disease: results at year 3

被引：3
|
作者：
D'Haens, Geert [1 ]
Reinisch, Walter [2 ]
Satsangi, Jack [3 ]
Loftus, Edward [4 ]
Panaccione, Remo [5 ]
Tokimoto, Debbie
Wang, Yaqin
Lomax, Kathleen
机构：
[1] Univ Amsterdam, Acad Med Ctr, Ctr Inflammatory Bowel Dis, NL-1105 AZ Amsterdam, Netherlands
[2] Med Univ Vienna, Vienna, Austria
[3] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Mayo Clin, Rochester, MN USA
[5] Univ Calgary, Calgary, AB T2N 1N4, Canada
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
10.1097/00054725-201112002-00068
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [21] LONG-TERM SAFETY OF ADALIMUMAB IN PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY
    D'Haens, Geert R.
    Reinisch, Walter
    Satsangi, Jack
    Loftus, Edward V.
    Panaccione, Remo
    Alperovich, Gabriela
    Kalabic, Jasmina
    Bereswill, Mareike
    Arikan, Dilek
    Petersson, Joel H.
    Robinson, Anne M.
    GASTROENTEROLOGY, 2017, 152 (05) : S137 - S137
  • [22] Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registry
    D'Haens, G.
    Reinisch, W.
    Satsangi, J.
    Loftus, E. V., Jr.
    Panaccione, R.
    Alperovich, G.
    Kalabic, J.
    Bereswill, M.
    Arikan, D.
    Petersson, J.
    Robinson, A. M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S256 - S257
  • [23] Adalimumab long-term effectiveness in adalimumab-naive patients with Crohn's disease: final data from PYRAMID registry
    Loftus, E., Jr.
    D'Haens, G.
    Reinisch, W.
    Satsangi, J.
    Panaccione, R.
    Berg, S.
    Alperovich, G.
    Bereswill, M.
    Kalabic, J.
    Skup, M.
    Petersson, J.
    Robinson, A. M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S422 - S423
  • [24] Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
    Straatmijer, Tessa
    Biemans, Vince B. C.
    Hoentjen, Frank
    de Boer, Nanne K. H.
    Bodelier, Alexander G. L.
    Dijkstra, Gerard
    van Dop, Willemijn A.
    Haans, Jeoffrey J. L.
    Jansen, Jeroen M.
    Maljaars, P. W. Jeroen
    van der Marel, Sander
    Oldenburg, Bas
    Ponsioen, Cyriel Y.
    Visschedijk, Marijn C.
    de Vries, Annemarie C.
    West, Rachel L.
    van der Woude, C. Janneke
    Pierik, Marieke
    Duijvestein, Marjolijn
    van der Meulen-de Jong, Andrea E.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (11): : 1920 - 1930
  • [25] USE OF ADALIMUMAB BIOSIMILAR ABP 501 IN CROHN'S DISEASE: AN OBSERVATIONAL STUDY
    Ribaldone, D. G.
    Vernero, M.
    Pellicano, R.
    Morino, M.
    Saracco, G. M.
    Astegiano, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S118 - S118
  • [26] PYRAMID Registry: Long-term Safety and Effectiveness of Adalimumab by Baseline Immunomodulator Use in Patients With Crohn's Disease
    Reinisch, Walter
    Panaccione, Remo
    D'Haens, Geert
    Loftus, Edward V., Jr.
    Satsangi, Jack
    Colombel, Jean-Frederic
    Alperovich, Gabriela
    Berg, Sofie
    Kalabic, Jasmina
    Bereswill, Mareike
    Petersson, Joel
    Robinson, Anne M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S384 - S384
  • [27] IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN'S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY
    Ahuja, Dhruv
    Luo, Jiyu
    Qi, Yuchen
    Syal, Gaurav
    Boland, Brigid
    Chang, John
    Ma, Christopher
    Jairath, Vipul
    Xu, Ronghui
    Singh, Siddharth
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S1 - S1
  • [28] IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN'S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY
    Ahuja, Dhruv
    Luo, Jiyu
    Qi, Yuchen
    Syal, Gaurav
    Boland, Brigid
    Chang, John
    Ma, Christopher
    Jairath, Vipul
    Xu, Ronghui
    Singh, Siddharth
    GASTROENTEROLOGY, 2024, 166 (03) : S1 - S1
  • [29] Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
    Fuminao Takeshima
    Daisuke Yoshikawa
    Syuntaro Higashi
    Tomohito Morisaki
    Hidetoshi Oda
    Maho Ikeda
    Haruhisa Machida
    Kayoko Matsushima
    Hitomi Minami
    Yuko Akazawa
    Naoyuki Yamaguchi
    Ken Ohnita
    Hajime Isomoto
    Masato Ueno
    Kazuhiko Nakao
    BMC Gastroenterology, 16
  • [30] Adalimumab and Infliximab As Induction Therapy for Crohn's Disease - A Prospective Observational Study in Germany
    Bokemeyer, Bernd
    Helwig, Ulf
    Teich, Niels
    Schmidt, Carsten
    Krummenerl, Thomas
    Rupf, Ann-Katrin
    Hartmann, Heinz
    Blaker, Michael
    Krummenerl, Annette
    Duffelmeyer, Marc
    Hinrichs, Regina
    Hartmann, Petra
    Nikolaus, Susanna
    Huppe, Dietrich
    Schreiber, Stefan
    GASTROENTEROLOGY, 2014, 146 (05) : S453 - S453
12345